USCWA
GILD icon

U.S. Capital Wealth Advisors’s Gilead Sciences GILD Stock Holding History

U.S. Capital Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.05M Sell
7,506
-246
-3% -$34.4K 0.03% 503
2025
Q4 		$951K Buy
7,752
+611
+9% +$74.3K 0.02% 505
2025
Q3 		$793K Sell
7,141
-74,087
-91% -$8.42M 0.02% 523
2025
Q2 		$9.01M Buy
81,228
+75,078
+1,221% +$7.99M 0.26% 99
2025
Q1 		$689K Sell
6,150
-555
-8% -$57.3K 0.02% 508
2024
Q4 		$619K Sell
6,705
-64,693
-91% -$5.82M 0.02% 518
2024
Q3 		$5.99M Sell
71,398
-4,373
-6% -$334K 0.21% 110
2024
Q2 		$5.2M Sell
75,771
-4,003
-5% -$267K 0.2% 113
2024
Q1 		$5.84M Sell
79,774
-3,296
-4% -$253K 0.22% 108
2023
Q4 		$6.73M Buy
83,070
+63,009
+314% +$4.9M 0.27% 92
2023
Q3 		$1.5M Sell
20,061
-2,733
-12% -$210K 0.07% 249
2023
Q2 		$1.76M Sell
22,794
-2,901
-11% -$231K 0.08% 236
2023
Q1 		$2.13M Sell
25,695
-528
-2% -$43.7K 0.1% 195
2022
Q4 		$2.25M Sell
26,223
-84,928
-76% -$6.73M 0.1% 188
2022
Q3 		$6.86M Sell
111,151
-645
-0.6% -$40.7K 0.35% 63
2022
Q2 		$6.91M Buy
111,796
+890
+0.8% +$55.1K 0.3% 68
2022
Q1 		$6.59M Sell
110,906
-544
-0.5% -$34.8K 0.24% 88
2021
Q4 		$8.09M Sell
111,450
-14,516
-12% -$1,000K 0.32% 74
2021
Q3 		$8.76M Buy
+125,966
New +$8.85M 0.38% 60

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

U.S. Capital Wealth Advisors's GILD Position: Q1 2026 in Review

U.S. Capital Wealth Advisors reduced its Gilead Sciences (GILD) stake by 3.2% in Q1 2026, selling an estimated $34.4K and leaving 7,506 shares worth $1.05M. The position accounts for 0.03% of the portfolio, ranked #503.

U.S. Capital Wealth Advisors first reported a position in GILD in Q3 2021 and has held it in 19 quarters since. The position peaked at $9.01M in Q2 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • U.S. Capital Wealth Advisors held 7,506 shares of Gilead Sciences worth $1.05M as of Q1 2026.
  • U.S. Capital Wealth Advisors sold 246 Gilead Sciences shares in Q1 2026, an estimated $34.4K.
  • Gilead Sciences made up 0.03% of U.S. Capital Wealth Advisors's portfolio in Q1 2026, its #503 holding.
  • U.S. Capital Wealth Advisors first reported a position in Gilead Sciences in Q3 2021 and has held it in 19 quarters since.
  • U.S. Capital Wealth Advisors's Gilead Sciences position peaked at $9.01M in Q2 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.